EKErcüment Keskin

Ercüment Keskin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ercüment Keskin has a total of 95 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Role of ureteral wall thickness and computed tomography imaging in predicting spontaneous passage of ureteral stones

    by Özlem Kadırhan, Sonay Aydın, Ercüment Keskin, Mecit Kantarcı

    Role of ureteral wall thickness and computed tomography imaging in predicting spontaneous passage of ureteral stones - Diagnostic and Interventional Radiology


  • Pelvik Organ Prolapsusu ve İdrar Kaçırma

    by Ercüment Keskin, Ayşenur Balıkçı

  • Open Access

    Güncel Üroloji Çalışmaları VII- İnkontinans (Bahar)

    by Furkan Abdullah Vural, Muratcan Toptaş, Ali Ertan Okatan, Nihat Karabacak, Berk Batuk, Tuncer Bahçeci, İbRahim Sibal, Mehmet Sefa Altay, Mahmut Uğurlu, Mustafa Kaba, et al.

    Pelvis Anatomisi Furkan Abdullah VURAL İşeme Fizyolojisi Ali Ertan OKATAN Üriner Kontinans Mekanizmaları Nihat KARABACAK Berk BATUK Üriner İnkontinans Prevalansı Tuncer BAHÇECİ Noktüri İbrahim SİBAL Üriner İnkontinansta Sınıflandırma ve Değerlendirme Mehmet Sefa ALTAY Alt Üriner Sistem Nöromusküler Disfonksiyonu Mahmut UĞURLU Aşırı Aktif Mesane Mahmut UĞURLU Kadınlarda Stres Tip İdrar Kaçırma Mustafa KABA İrem Aleyna TEKE Pelvik Organ Prolapsusu ve İdrar Kaçırma Ercüment KESKİN Ayşenur BALIKÇI Geriatrik Hastalarda Alt Üriner Sistem Bozuklukları ve İdrar Kaçırma Nurşah SARIDUMAN Ahmet Eren DEMİRTOLA Post-Prostatektomi İnkontinans Ali Ertan OKATAN Mesane Ağrı Sendromu (İnterstisyel Sistit) Ömür MEMİK Genitoüriner Sistem Fistülleri Ali Erhan EREN Baran ARSLAN Nokturnal Enürezis Kadir Şerefhan ERTEN Damla Nur TATLI ŞAHİN Kadınlarda Üretral Divertiküller Görkem AKÇA Selim YAZAR Üriner İnkontinansta Medikal Tedaviler İlke Onur KAZAZ Nurettin KOLLU Üriner İnkontinans Cerrahi Tedavisi İlke Onur KAZAZ Abdullah Harun BAYRAM

  • Open Access

    Intravesical BCG: A Double-Edged Sword? The Untold Story of Infection Risks

    by Orçun Barkay, Ercüment Keskin

    Background and Objectives: Intravesical Bacillus Calmette-Guérin (BCG) therapy remains a cornerstone in the treatment of non-muscle-invasive bladder carcinoma due to its efficacy in reducing recurrence and progression rates. However, its use is associated with various complications—including urinary tract infections (UTIs)—which necessitates further exploration. This study aims to analyze UTIs occurring during intravesical BCG treatment, emphasizing the microbial spectrum, resistance patterns, and risk factors from an infectious diseases and clinical microbiology perspective. Materials and Methods: A retrospective analysis was conducted on 240 patients diagnosed with non-muscle-invasive bladder carcinoma who received intravesical BCG therapy between 2010 and 2021. Data were collected from hospital records, including demographic characteristics, comorbidities, number of intravesical BCG cycles, and microbiological findings. UTIs were classified based on susceptibility patterns, and statistical analyses were performed to determine associations between clinical variables and UTI risk. Results: UTIs developed in 39.1% (n = 94) of patients, with 25.8% (n = 62) caused by susceptible pathogens and 13.3% (n = 32) by resistant pathogens. The most common causative agent was Escherichia coli (80.7% in susceptible UTIs, 43.8% in resistant UTIs), followed by Pseudomonas aeruginosa and Klebsiella pneumoniae. The presence of diabetes mellitus and chronic kidney disease significantly increased the risk of developing a UTI (p < 0.05). A higher number of intravesical BCG cycles correlated with increased UTI occurrence (p < 0.001). Serum C-reactive protein (CRP) levels were significantly elevated in patients with resistant UTIs, while procalcitonin levels were not a reliable predictor of UTI occurrence. Conclusions: Intravesical BCG therapy is associated with a significant incidence of UTIs, particularly among patients with predisposing comorbidities. The increasing prevalence of antibiotic-resistant infections underscores the need for careful monitoring and targeted antimicrobial stewardship strategies. CRP may serve as a useful adjunctive marker for UTI diagnosis in this setting. Future studies should focus on optimizing infection control measures and refining diagnostic criteria to differentiate between BCG-related inflammation and infectious complications.


  • Open Access

    Güncel Üroloji Çalışmaları VI - Prostat Hastalıkları

    by Mehmet Ali Karagöz, Görkem Akça, Mahmut Uğurlu, Furkan Abdullah Vural, Erdem Orman, Cihat Özcan, Kürşad Dönmez, Enis Mert Yorulmaz, İlKe Onur Kazaz, Recep Serhat Tepe, et al.

    Prostat Anatomisi Mehmet Ali KARAGÖZ Prostat Enfeksiyonları Görkem AKÇA Benign Prostat Hiperplazisinde Etyoloji ve Patogenez Mahmut UĞURLU Furkan Abdullah VURAL Bph Tedavi Yöntemleri Erdem ORMAN Bph Tedavisinde Lazer Kullanımı Cihat ÖZCAN Prostat Kanserinde Etiyoloji, Epidemiyoloji, Tanı ve Evreleme Enis Mert Yorulmaz Prostat Biyopsi Yöntemleri İlke Onur KAZAZ Recep Serhat TEPE Lokalize Prostat Kanserinde Tanı ve Tedavi Mücahit KABAR Radikal Prostatektomi Cerrahisi Sonrası İzlem ve Komplikasyon Yönetimi Olcay KARAOĞLU Lokal İleri Hastalıkta Tedavi Yöntemleri Mubariz AYDAMIROV Kadir KARKIN Metastatik Prostat Kanserinde Tedavi Seher Nazlı KAZAZ Göktuğ ATNALLAR Prostat Kanseri Tedavisi Sonrası Erektil Disfonksiyona Yaklaşım Nihat KARABACAK Cihat AYTEKIN Çocuklarda Prostat ve Genitoüriner Travmalar Nur Deniz EYÜPOĞLU KARAOĞLU Olcay KARAOĞLU Bening Prostat Hiperplazisine Bağlı Postrenal Azotemi Ercüment KESKİN Ömer BÜYÜKTEPE

  • Open Access

    INVESTIGATION OF INFLAMMATORY MARKER LEVELS IN OVERACTIVE BLADDER PATIENTS

    by Ozgur Ekıcı, Abdullah Gül, Ali Seydi Bozkurt, Ercüment Keski̇n, Volkan Çağlayan, Abdullah Erdoğan, Uğur Akgün, Omer Buyuktepe

    Aim: To investigate whether inflammation plays a role in the pathogenesis of patients diagnosed with overactive bladder (OAB). Material-Method: Patients who applied to the urology outpatient clinic with a preliminary diagnosis of OAB between March 2022 and September 2023 and were diagnosed were prospectively included in the study. Demographic data of the patients, such as age, gender and body mass index (BMI), were recorded. The number of urgency attacks, pollakiuria and nocturia, OAB-V8 scores (0-40) and the anticholinergics used were recorded. Blood group, whole blood and biochemical values measured from peripheral blood at outpatient clinic admissions, among the inflammation markers neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), lymphocyte-monocyte ratio (LMR), C reactive protein/albumin (CRP/Albumin) ratio and Deritis (AST/ALT) ratios were recorded. Patients with urinary tract infection, renal function test abnormalities, and patients with a history of previous urological surgery were excluded from the study. Patients who presented to the outpatient clinic with non-OAB were included as the control group. Hemogram and biochemical values of these patients were also recorded. Data recorded at baseline were compared between groups. Results: A total of 198 patients were included in the study (OAB group n: 99, control group n: 99). The mean age of all patients was 52.3±15 years, and the mean OAB-V8 score was 11.9±9.9. No statistically significant difference was observed between the groups in terms of gender and blood group. No statistically significant difference was observed between the groups in terms of hemoglobin, hematocrit, lymphocyte, platelet, AST, ALT, albumin, NLR, LMR, PLR, Deritis, MLR and CRP/albumin ratio. The mean age of the OAB group was found to be significantly higher than the control group (p

  • Open Access

    Can atherogenic indices and the triglyceride-glucose index be used to predict erectile dysfunction?

    by Murat Sambel, Abdullah Erdogan, Volkan Caglayan, Sinan Avci, Sahin Kilic, Halil Emre Yildiz, Ercument Keskin

    Atherosclerosis and insulin resistance play an important role in the development of erectile dysfunction (ED), and few studies have comprehensively evaluated more specific indicators like atherogenic indices and the triglyceride-glucose (TyG) index in the assessment of ED. This study aimed to reveal the role of atherogenic indices (atherogenic index of plasma [AIP], Castelli risk index-1/2 [CRI-1/2], and atherogenic coefficient [AC]) based on plasma lipid ratios, which have been used as more sensitive indicators of atherosclerosis in recent years, and the TyG index, a practical indicator of insulin resistance, in predicting vasculogenic ED. The study included a total of 199 patients who met the inclusion criteria and a total of 51 control subjects without ED complaints according to the International Index of Erectile Function (IIEF-5) scores (>21) between May 2021 and October 2022. For all participants, the demographic and biochemical parameters were evaluated, and atherogenic indices, namely CRI-1 (total cholesterol/high-density lipoprotein [HDL]), CRI-2 (LDL/HDL) AIP [log10(triglycerides/HDL)], and AC (non-HDL/HDL), as well as the TyG index [Ln {fasting triglycerides (mg/dL) × fasting glucose (mg/dL)/2}] were calculated. The TyG index, which is an indicator of insulin resistance, and atherogenic indices such as CRI-1, AIP, and AC were significantly associated with ED, and especially AIP and the TyG index seem to be more important in the evaluation of ED. According to the univariate analysis, the patient group had significantly higher CRI-1 (5.3 ± 1.4 vs 4.7 ± 1.3; P = .005), AIP (0.31 ± 0.26 vs 0.13 ± 0.2; P < .001), AC (4.1 ± 1.4 vs 3.70 ± 1.2; P = .026), and TyG (9.16 ± 0.71 vs 8.77 ± 0.52; P < .001) values compared with the control group. In the correlation analysis, a significant negative correlation was found between the AIP and TyG index and the IIEF-5 scores (r2 = 0.120, P < .001 between AIP and IIEF-5; r2 = 0.091, P < .001 between TyG index and IIEF-5). The multivariate analysis revealed AIP and the TyG index as independent predictive factors for ED. The use of atherogenic indices and TyG index in daily urology practice can help physicians in the diagnosis and follow-up of ED. The lack of sex hormone–binding globulin and free testosterone levels represents a limitation of our study. Another limitation is that the severity of ED was determined using the IIEF-5 scores, rather than a more objective method, such as penile artery ultrasound. Atherogenic indices and the TyG index can be used as inexpensive and practical markers to predict the severity of arteriogenic ED.


  • Effect of sunitinib on testicular oxidative and proinflammatory damage induced by ischemia–reperfusion in rats

    by Ercument Keskin, Abdullah Erdogan, Halis Suleyman, Gulce Naz Yazici, Mukadder Sunar, Mehmet Ali Gul


  • Comparison of serum Kim-1 and Miox levels in patients that underwent percutaneous nephrolithotomy and flexible ureterorenoscopy

    by Abdulsemet Altun, Aliseydi Bozkurt, Abdullah Erdogan, Cuma Mertoğlu, Erkan Hirik, Ercüment Keskin, Abdullah Turan

    Objective: Percutaneous nephrolithotomy (PNL) and retrograde intrarenal surgery (RIRS) are common surgical methods in the treatment of kidney stones. Possible effects on kidneys are an important factor in determining the surgical procedure and the surgical method. In our study, kidney injury molecule-1 (KIM-1) and myo-inositol oxygenase (MIOX) were used to compare acute kidney injury in patients that underwent PNL and RIRS. Material and Method: Eighty patients aged 20–75, who underwent PNL or RIRS in our urology clinic between November 2018 and February 2020 were included in the study. In this prospective study, the demographic characteristics, stone size, operation time, preoperative and postoperative hemoglobin and biochemistry values of the patients were recorded. About 5 cc blood samples taken from the patients before the operation and at the fourth hour after the operation were centrifuged and kept at −80°C, and the KIM-1 and MIOX levels were measured in the biochemistry department. Results: There was no difference between the groups in terms of demographic data; however, the operation time and length of hospital stay were significantly longer in the PNL group. The mean increase in MIOX was 10.583 ± 9.73 and 7.501 ± 16.46 ng/ml in the PNL and RIRS groups, respectively. Although there was a statistically significant increase in both groups, this increase was greater in the PNL group. A significant increase was observed only in the PNL group in the postoperative period ( p = 0.003). Discussion and Conclusion: The findings of the study suggest that the PNL procedure causes more damage to the kidneys than RIRS.


  • Development of a Novel Nomogram and a Simple Scoring System Using Ureteral Jet Flow to Predict Impacted Ureteral Stone

    by Abdullah Erdogan, Ercument Keskin, Murat Sambel, Salih Polat, Mehmet Kocak, Ozkan Kilinc

    Purpose: To examine the efficacy of ureteral jet flow measured by Doppler ultrasonography (USG) together with radiological parameters obtained by noncontrast enhanced CT in predicting whether a ureteral stone is impacted. Materials and Methods: A total of 178 patients that met the criteria were included in the study. Stone size, location, grade of hydronephrosis, HU values of the stone and the proximal and distal parts of the stone, and ureteral wall thickness (UWT) were obtained from noncontrast enhanced abdominal CT images. Ureteral jet flows ( V max ) were measured and recorded by Doppler USG. Thirty-eight cases in whom the guidewire or opaque contrast material could not pass beyond the stone were included in the impacted ureteral stone (IUS) group, whereas the remaining 140 patients constituted the non-IUS (non-IUS) group. Results: Significant independent predictors of IUS were determined as stone size (odds ratio [OR]: 2.23, p = 0.020), ureteral HU value under the stone (OR: 1.11, p = 0.014), UWT (OR: 5.66, p = 0.009), anteroposterior diameter (OR: 1.23, p = 0.033), and the V max value of the stone side (OR: 0.76, p = 0.011). The proposed scoring system predicted IUS with 89% sensitivity and 91% specificity at a cutoff value of 11.5. Conclusion: Determining whether a ureteral stone is impacted is important in deciding on the optimal treatment modality. The nomogram and scoring system that we created based on the data that were obtained with noninvasive methods can predict IUS with high sensitivity and specificity.